Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) - PAR-25-111
Funder
National Institutes of Health
LOI Deadline
;
LOI Required
Recommended, but not required
Application Deadline
;
Maximum Project Duration
2 years
Research Focus Areas
Pharmacology
Precision Health
Population Focus
Maternal/Perinatal/Postpartum
Children/Infants
Research Methods
Randomized Control Trials (RCT)
Description
The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating persons, neonates, and children.